You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

FENOFIBRIC ACID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Fenofibric Acid, and what generic alternatives are available?

Fenofibric Acid is a drug marketed by Actavis Elizabeth, Alembic, Aurobindo Pharma Ltd, Chartwell Rx, Endo Operations, Impax Labs Inc, Macleods Pharms Ltd, Micro Labs, Norvium Bioscience, Rising, Twi Pharms, and Yichang Humanwell. and is included in twelve NDAs.

The generic ingredient in FENOFIBRIC ACID is choline fenofibrate. There are one hundred and two drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the choline fenofibrate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FENOFIBRIC ACID?
  • What are the global sales for FENOFIBRIC ACID?
  • What is Average Wholesale Price for FENOFIBRIC ACID?
Summary for FENOFIBRIC ACID
Drug patent expirations by year for FENOFIBRIC ACID
Drug Prices for FENOFIBRIC ACID

See drug prices for FENOFIBRIC ACID

Recent Clinical Trials for FENOFIBRIC ACID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Chong Kun Dang PharmaceuticalPhase 1
Federal University of São PauloPhase 4
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4

See all FENOFIBRIC ACID clinical trials

Pharmacology for FENOFIBRIC ACID

US Patents and Regulatory Information for FENOFIBRIC ACID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 200920-001 Oct 7, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 200913-002 Mar 25, 2013 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Yichang Humanwell FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 212562-002 Dec 23, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 200750-001 Dec 4, 2013 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.